CLOs on the Move

Heartland Blood Ctr

www.heartlandbc.org

 
Founded in 1943, Heartland Blood Centers' mission is to provide and maintain an adequate supply of blood and blood products for area hospitals to draw upon to meet the needs of patients.
  • Number of Employees: 0-25
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Integrated Health Network of Wisconsin

Integrated Health Network (IHN) of Wisconsin is the state’s first multi-system, clinically integrated accountable care network and one of the first in the United States. It is a consortium of independent health systems, hospitals and physicians working together to improve the quality, efficiency and value of health care. Since its launch in 2010, IHN has been transforming health care delivery with our clinically integrated network of leading health care providers and our sophisticated infrastructure for data analytics. The result is a model that delivers high quality health care and the cost savings of a narrow network, combined with the scale and value only possible through the breadth of a larger system.

NYU Langone Medical Center

NYU Langone Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New York, NY. To find more information about NYU Langone Medical Center, please visit www.nyumc.org

Healthy Alliance

Healthy Alliance is a network that brings together organizations to coordinate and collaborate so that all communities have reliable access to the resources they need to improve health and empower the underserved.

Safeware

Safeware is a safety supply company that provides safety products and technical services to customers in the industrial, government, military, and response markets.

Maverick Therapeutics

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.